FGFR3 mutations only occurred in HPV/p16 positive tumors and the distributions of the PIK3CA, PTEN, FBXW7 or the presence of multiple mutations did not differ between the HPV/p16 negative and HPV/p16 positive carcinomas (p = 0. This evidence concerns the gene CDKN2A and carcinoma.